Navigation Links
Uniform analyses for clean drinking water in Europe
Date:12/10/2009

This release is available in German.

Clean water is a matter of survival for humans, particularly when it is used for drinking, cooking and for food manufacture. Therefore, the EU member countries have in several guidelines undertaken to guarantee their citizens sustainable clean drinking water. The requirement for this is, however, a water analysis that provides the exact values for possible toxic substances, which are then also internationally comparable. Therefore, scientists from the Physikalisch-Technische Bundesanstalt (PTB), together with researchers from the University of Stuttgart (AQS BW) and the Rhenish-Westphalian Institute for Water Research (IWW) have worked out new metrological concepts as to how the comparability of measurement results can be achieved without additional time and effort. For this work, in November, the researchers received the CITAC Award 2009.

CITAC stands for Cooperation on International Traceability in Analytical Chemistry and is an association of representatives of important industrial countries from all continents. Their goal is to improve the traceability in chemistry at the global level. The international comparability of analytical measurement results is to be ensured, independent of the time and place of its origin. This is of crucial importance for achieving uniform standards of quality for drinking water in all the European countries.

Nationally and internationally, chemical measurements are compared as a rule by round-robin tests. Hereby, the participating laboratories receive samples of unknown concentration for analysis. Until now, a result was deemed to be good if it was as close as possible to the mean value of all participants' results. This so-called consensus value can, however, clearly deviate from the actual concentration and thus possesses a correspondingly large uncertainty. The new c
'/>"/>

Contact: Detlef Schiel
detlef.schiel@ptb.de
49-531-592-3110
Physikalisch-Technische Bundesanstalt (PTB)
Source:Eurekalert

Page: 1 2

Related biology news :

1. Species diversity helps ASU researchers refine analyses of human gene mutations
2. LSU researchers challenge analyses on sustainability of Gulf fisheries
3. Research is vital to a cleaner, greener, low carbon future
4. Genomic research will enable greener cleanup of military explosive test sites
5. RIT scientist shines laser light on methane in pursuit of clean fuel
6. Developing enzymes to clean up pollution by explosives
7. LLNL technology cleans up Visalia Superfund 100 years ahead of schedule
8. Hot microbes cause groundwater cleanup rethink
9. LSU receives $3.6 million to fund center studying hazardous waste cleanup and health impacts
10. Clean fuels could reduce deaths from ship smokestacks by 40,000 annually
11. New cleaning protocol for future search for life missions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... July 07, 2015 ... addition of the "Biometrics for Banking; Market ... report to their offering. The ... to this growth and the forecast is that ... revenue for companies involved in delivering biometric systems ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... attained very promising results on their initial investigations of a ... mass spectrometry of a single drop of blood serum, the ... of the patients tested. The results can be found online ... . "Because ovarian cancer is a disease of ...
... As much as 12 percent of the worlds human-caused greenhouse ... charcoal-like substance made from plants and other organic materials. Thats ... and materials were burned to generate energy, concludes a study ... calculations show that biochar can play a significant role in ...
... marine mosasaur Platecarpus , lived in the Cretaceous Period some ... an eel. That theory is debunked in a new paper published ... of scientists have reconceived the animal,s morphology, or body plan, based ... Los Angeles County. The paper was co-authored by ...
Cached Biology News:Initial trials on new ovarian cancer tests exhibit extremely high accuracy 2Charcoal takes some heat off global warming 2Charcoal takes some heat off global warming 3Charcoal takes some heat off global warming 4Charcoal takes some heat off global warming 5Mosasaur fossil at Natural History Museum of L.A. County re-explores 85-million-year-old sea monster 2
(Date:8/3/2015)... Aug. 3, 2015  ArroGen Group, an integrated ... Fingerprint Molecular Identification™ (FMID) technology Aug. 2-8 at ... Sacramento, Calif. ... enable law enforcement agents, district attorneys and government ... suspects. By analyzing chemical residues on ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Nine field ... Iowa, Illinois and Indiana. Hosted by the Soil Health Partnership , the field ... lasting environmental benefits while potentially increasing farm productivity and income. , Brent Bible has ...
(Date:8/3/2015)... , Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... focused on the development of autologous cell therapies, announced today ... at the InvestMNT conference held in Minneapolis, Minnesota ... local time. Hall,s presentation will highlight RepliCel,s 18-month milestones including ... Europe , clinical data from both RCT-01 ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud to announce ... gluten in foods, has been accepted by AOAC International as Official First Action ... Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific monoclonal antibody ...
Breaking Biology Technology:ArroGen Previews New Fingerprint Molecular Identification Technology 2Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2
... TGH to Enhance Clinical Skills,Development, DENVER, Nov. ... partnership with the University of South Florida (USF) ... Health hospital,partners and for local and national health ... Center is located at Tampa,General Hospital, a major ...
... 10 NeurogesX, Inc.,(Nasdaq: NGSX ), a ... management therapies, announced today that,Anthony DiTonno, President and ... Rodman & Renshaw 10th Annual Healthcare Conference in ... DiTonno and Stephen Ghiglieri,Chief Financial Officer, will also ...
... Company Registered in Switzerland, Will Move its Headquarter ... Various Issues Related to Neovascularisation, - Gene Signal is Working ... Now in Phase III Trials, - Gene Signal Will Present ... the American Academy of Ophtalmologist in Atlanta, USA, the ...
Cached Biology Technology:Medical Simulation Corporation Announces Partnership With University of South Florida 2Medical Simulation Corporation Announces Partnership With University of South Florida 3NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 3Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection 2Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection 3
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis....
Loading Buffer...
Request Info...
Request Info...
Biology Products: